Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...
Global Bioanalytical Services Market is anticipated to witness a healthy double-digit growth rate by 2027. The rising ...
The Global Home Healthcare Services Market will witness a CAGR of 9-10% by 2029. The key factors driving the home healthcare ...
The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...
In Response to Continued Growth, Simulab Corporation Adds Salmonsen to the Leadership Team SEATTLE, WASHINGTON / ACCESS ...
Cracking the Code on Interoperability with Scalable, Vendor-Neutral Architectures Powering AI-Ready Health Systems Worldwide ...
CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") announces that on March 28, 2025, it mutually agreed with SunRegen Healthcare AG ("SunRegen") ...
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data with TH104-Advancing CMC plan to meet requirements of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback